Alaa Elmetwalli

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 37

Top Topics

Helicobacter Pylori Infection

Top Venues

Medical oncology (Northwood, London, England)

BMC microbiology

Naunyn-Schmiedeberg's archives of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Correction to: Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (5) (2024)
Alaa Elmetwalli, Mohamed O Abdel-Monem, Ali H El-Far, Gehad S Ghaith, Noaf Abdullah N Albalawi, Jihan Hassan, Nadia F Ismail, Tarek El-Sewedy, Mashael Mashal Alnamshan, Nouf K ALaqeel, Ibtesam S Al-Dhuayan, Mervat G Hassan
Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment. Medical oncology (Northwood, London, England) 41 (5) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Alaa Elmetwalli, Mohamed O Abdel-Monem, Ali H El-Far, Gehad S Ghaith, Noaf Abdullah N Albalawi, Jihan Hassan, Nadia F Ismail, Tarek El-Sewedy, Mashael Mashal Alnamshan, Nouf K ALaqeel, Ibtesam S Al-Dhuayan, Mervat G Hassan
Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment. Medical oncology (Northwood, London, England) 41 (5) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Alaa Elmetwalli, Mohamed O Abdel-Monem, Ali H El-Far, Gehad S Ghaith, Noaf Abdullah N Albalawi, Jihan Hassan, Nadia F Ismail, Tarek El-Sewedy, Mashael Mashal Alnamshan, Nouf K ALaqeel, Ibtesam S Al-Dhuayan, Mervat G Hassan
Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment. Medical oncology (Northwood, London, England) 41 (5) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Alaa Elmetwalli, Mohamed O Abdel-Monem, Ali H El-Far, Gehad S Ghaith, Noaf Abdullah N Albalawi, Jihan Hassan, Nadia F Ismail, Tarek El-Sewedy, Mashael Mashal Alnamshan, Nouf K ALaqeel, Ibtesam S Al-Dhuayan, Mervat G Hassan
Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment. Medical oncology (Northwood, London, England) 41 (5) (2024)
Alaa Elmetwalli, Mohamed O Abdel-Monem, Ali H El-Far, Gehad S Ghaith, Noaf Abdullah N Albalawi, Jihan Hassan, Nadia F Ismail, Tarek El-Sewedy, Mashael Mashal Alnamshan, Nouf K ALaqeel, Ibtesam S Al-Dhuayan, Mervat G Hassan
Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment. Medical oncology (Northwood, London, England) 41 (5) (2024)
Alaa Elmetwalli, Mohamed O Abdel-Monem, Ali H El-Far, Gehad S Ghaith, Noaf Abdullah N Albalawi, Jihan Hassan, Nadia F Ismail, Tarek El-Sewedy, Mashael Mashal Alnamshan, Nouf K ALaqeel, Ibtesam S Al-Dhuayan, Mervat G Hassan
Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment. Medical oncology (Northwood, London, England) 41 (5) (2024)
Alaa Elmetwalli, Mohamed O Abdel-Monem, Ali H El-Far, Gehad S Ghaith, Noaf Abdullah N Albalawi, Jihan Hassan, Nadia F Ismail, Tarek El-Sewedy, Mashael Mashal Alnamshan, Nouf K ALaqeel, Ibtesam S Al-Dhuayan, Mervat G Hassan
Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment. Medical oncology (Northwood, London, England) 41 (5) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Correction to: Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (5) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Correction to: Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (5) (2024)
Eman Helal, Fatma Elgebaly, Nasser Mousa, Sherif Elbaz, Mostafa Abdelsalam, Eman Abdelkader, Amr El-Sehrawy, Niveen El-Wakeel, Ola El-Emam, Manal Hashem, Alaa Elmetwalli, Shimaa Mansour
Diagnostic performance of new BAST score versus FIB-4 index in predicating of the liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease. European journal of medical research 29 (1) (2024)
Aeshah Hamdan Almutairi, Nayef Shabbab Almutairi, Nasser Mousa, Ashraf Elsayed, Amr El-Sehrawy, Alaa Elmetwalli
Aerobic exercise as a non-pharmacological intervention for improving metabolic and hemodynamic profiles in type 2 diabetes. Irish journal of medical science (2024)
Aisha Nawaf Al Balawi, Alaa Elmetwalli, Dina M Baraka, Hadeer A Alnagar, Eman Saad Alamri, Mervat G Hassan
Chemical Constituents, Antioxidant Potential, and Antimicrobial Efficacy of Pimpinella anisum Extracts against Multidrug-Resistant Bacteria. Microorganisms 11 (4) (2023)
Aisha Nawaf Al Balawi, Alaa Elmetwalli, Dina M Baraka, Hadeer A Alnagar, Eman Saad Alamri, Mervat G Hassan
Chemical Constituents, Antioxidant Potential, and Antimicrobial Efficacy of Pimpinella anisum Extracts against Multidrug-Resistant Bacteria. Microorganisms 11 (4) (2023)
Alaa Elmetwalli, Thoria Diab, Aisha Nawaf Albalawi, Sabry Ali El-Naggar, Ali H El-Far, Amira Radwan Ghedan, Eman Saad Alamri, Afrah Fatthi Salama
Diarylheptanoids/sorafenib as a potential anticancer combination against hepatocellular carcinoma: the p53/MMP9 axis of action. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Aisha Nawaf Al Balawi, Alaa Elmetwalli, Dina M Baraka, Hadeer A Alnagar, Eman Saad Alamri, Mervat G Hassan
Chemical Constituents, Antioxidant Potential, and Antimicrobial Efficacy of Pimpinella anisum Extracts against Multidrug-Resistant Bacteria. Microorganisms 11 (4) (2023)
Alaa Elmetwalli, Aly Nageh, Amany I Youssef, Magda Youssef, Mohamed Abd El-Rahman Ahmed, Ahmed E Noreldin, Tarek El-Sewedy
Ammonia scavenger and glutamine synthetase inhibitors cocktail in targeting mTOR/β-catenin and MMP-14 for nitrogen homeostasis and liver cancer. Medical oncology (Northwood, London, England) 41 (1) (2023)
Alaa Elmetwalli, Nanis G Allam, Mervat G Hassan, Aisha Nawaf Albalawi, Azza Shalaby, Karim Samy El-Said, Afrah Fatthi Salama
Evaluation of Bacillus aryabhattai B8W22 peroxidase for phenol removal in waste water effluents. BMC microbiology 23 (1) (2023)
Tarek El-Sewedy, Afrah Fatthi Salama, Amro E Mohamed, Nashwa M Elbaioumy, Ali H El-Far, Aisha Nawaf Albalawi, Alaa Elmetwalli
Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death. BMC complementary medicine and therapies 23 (1) (2023)
Alaa Elmetwalli, Nanis G Allam, Mervat G Hassan, Aisha Nawaf Albalawi, Azza Shalaby, Karim Samy El-Said, Afrah Fatthi Salama
Evaluation of Bacillus aryabhattai B8W22 peroxidase for phenol removal in waste water effluents. BMC microbiology 23 (1) (2023)
Aisha Nawaf Al Balawi, Alaa R El-Alosey, Jayda G Eldiasty, Ismail Y H Abushalfeh, Angod Ahmed Almasaude, Sahar Abd-El Razik Mosallam, Alaa Elmetwalli
Perceptions of medicinal herbal products during the COVID-19 pandemic period among Saudi patients: a cross-sectional study. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Alaa Elmetwalli, Nanis G Allam, Mervat G Hassan, Aisha Nawaf Albalawi, Azza Shalaby, Karim Samy El-Said, Afrah Fatthi Salama
Evaluation of Bacillus aryabhattai B8W22 peroxidase for phenol removal in waste water effluents. BMC microbiology 23 (1) (2023)
Alaa Elmetwalli, Aly Nageh, Amany I Youssef, Magda Youssef, Mohamed Abd El-Rahman Ahmed, Ahmed E Noreldin, Tarek El-Sewedy
Ammonia scavenger and glutamine synthetase inhibitors cocktail in targeting mTOR/β-catenin and MMP-14 for nitrogen homeostasis and liver cancer. Medical oncology (Northwood, London, England) 41 (1) (2023)
Alaa Elmetwalli, Nanis G Allam, Mervat G Hassan, Aisha Nawaf Albalawi, Azza Shalaby, Karim Samy El-Said, Afrah Fatthi Salama
Evaluation of Bacillus aryabhattai B8W22 peroxidase for phenol removal in waste water effluents. BMC microbiology 23 (1) (2023)
Aisha Nawaf Al Balawi, Alaa Elmetwalli, Dina M Baraka, Hadeer A Alnagar, Eman Saad Alamri, Mervat G Hassan
Chemical Constituents, Antioxidant Potential, and Antimicrobial Efficacy of Pimpinella anisum Extracts against Multidrug-Resistant Bacteria. Microorganisms 11 (4) (2023)
Alaa Elmetwalli, Neamat H Kamosh, Rania El Safty, Amany I Youssef, Mohammed M Salama, Khaled M Abd El-Razek, Tarek El-Sewedy
Novel phloretin-based combinations targeting glucose metabolism in hepatocellular carcinoma through GLUT2/PEPCK axis of action: in silico molecular modelling and in vivo studies. Medical oncology (Northwood, London, England) 41 (1) (2023)
Alaa Elmetwalli, Shimaa Mustafa Hashish, Mervat G Hassan, Mohammed Abu El-Magd, Sabry Ali El-Naggar, Amina M Tolba, Afrah Fatthi Salama
Modulation of the oxidative damage, inflammation, and apoptosis-related genes by dicinnamoyl-L-tartaric acid in liver cancer. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Alaa Elmetwalli, Aly Nageh, Amany I Youssef, Magda Youssef, Mohamed Abd El-Rahman Ahmed, Ahmed E Noreldin, Tarek El-Sewedy
Ammonia scavenger and glutamine synthetase inhibitors cocktail in targeting mTOR/β-catenin and MMP-14 for nitrogen homeostasis and liver cancer. Medical oncology (Northwood, London, England) 41 (1) (2023)
Attia Ahmed Attia, Afrah Fatthi Salama, Jayda G Eldiasty, Sahar Abd El-Razik Mosallam, Sabry Ali El-Naggar, Mohammed Abu El-Magd, Hebatala M Nasser, Alaa Elmetwalli
Amygdalin potentiates the anti-cancer effect of Sorafenib on Ehrlich ascites carcinoma and ameliorates the associated liver damage. Scientific reports 12 (1) (2022)